Literature DB >> 16279223

[Blistering autoimmune dermatoses (II): therapy].

Matthias Goebeler1, Cassian Sitaru, Detlef Zillikens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16279223

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  6 in total

Review 1.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

2.  [Linear IgA disease of the oral mucosa with pharyngeal and esophageal involvement].

Authors:  P Sertznig; M Megahed
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

Review 3.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

Review 4.  [Optimizing therapy in patients with severe autoimmune blistering skin diseases].

Authors:  E Schmidt
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

5.  [Gold. Effective therapy for mucosal lesions of pemphigus vulgaris].

Authors:  D Lange; F Meiss; E Fiedler; K Treiber; W C Marsch; M Fischer
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

Review 6.  Autoimmunity against type VII collagen in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.